Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal Kumar Deb

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drug Delivery and Translational Research|May 7, 2024
Ti<sub>3</sub>C<sub>2</sub> (MXene), an advanced carrier system: role in photothermal, photoacoustic, enhanced drugs delivery and biological activity in cancer therapyVishal Kumar Deb, Utkarsh Jain
International Journal of Biological Macromolecules|August 26, 2025
Activation of transforming growth factor beta 1 through integrin alpha V beta 6 and its molecular insights into cancer progression, and future directionsVishal Kumar Deb, Utkarsh Jain
European Journal of Pharmacology|December 26, 2024
Deciphering TGF-β1's role in drug resistance and leveraging plant bioactives for cancer therapyVishal Kumar Deb, Nidhi Chauhan, Utkarsh Jain
Journal of Biotechnology|June 15, 2025
Conventional to bacteria-based cancer therapy through bacterial components and drug delivery approaches: Pre-clinical, clinical, and future progressionRomi Shreshtha, Vishal Kumar Deb, Ankita Ghosh, et al.
Bioorganic Chemistry|February 15, 2024
Recent advances in antimicrobial peptide-based therapyAditya Mulukutla, Romi Shreshtha, Vishal Kumar Deb, et al.
Steroids|September 25, 2024
Evaluation of structural features of anabolic-androgenic steroids: entanglement for organ-specific toxicityAnkan Sinha, Vishal Kumar Deb, Abhijit Datta, et al.
Biofactors (Oxford, England)|February 4, 2025
Leveraging supramolecular systems in biomedical breakthroughsShreya Maity, Vishal Kumar Deb, Sayani Mondal, et al.
Frontiers in Bioengineering and Biotechnology|April 27, 2026
Advancements in nanomedicines for cancer therapy: targeting molecular signaling pathways, activating immune cells, and using photothermal immunomodulationVishal Kumar Deb, Abhishek Mukherjee, Surajit Pathak, et al.
Frontiers in Pharmacology|July 2, 2025
Pharmacological potential of natural chalcones: a recent studies and future perspectiveSuman Adhikari, Priyatosh Nath, Vishal Kumar Deb, et al.
Chempluschem|October 30, 2025
Metal Meets Nucleobase: A Cd(II)-Adenine Complex with Bridging Supramolecular Architectures and Antibacterial ActivitySourav Nath, Tanushree Sen, Vishal Kumar Deb, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drug Delivery and Translational Research|May 7, 2024
Ti<sub>3</sub>C<sub>2</sub> (MXene), an advanced carrier system: role in photothermal, photoacoustic, enhanced drugs delivery and biological activity in cancer therapyVishal Kumar Deb, Utkarsh Jain
International Journal of Biological Macromolecules|August 26, 2025
Activation of transforming growth factor beta 1 through integrin alpha V beta 6 and its molecular insights into cancer progression, and future directionsVishal Kumar Deb, Utkarsh Jain
European Journal of Pharmacology|December 26, 2024
Deciphering TGF-β1's role in drug resistance and leveraging plant bioactives for cancer therapyVishal Kumar Deb, Nidhi Chauhan, Utkarsh Jain
Journal of Biotechnology|June 15, 2025
Conventional to bacteria-based cancer therapy through bacterial components and drug delivery approaches: Pre-clinical, clinical, and future progressionRomi Shreshtha, Vishal Kumar Deb, Ankita Ghosh, et al.
Bioorganic Chemistry|February 15, 2024
Recent advances in antimicrobial peptide-based therapyAditya Mulukutla, Romi Shreshtha, Vishal Kumar Deb, et al.
Steroids|September 25, 2024
Evaluation of structural features of anabolic-androgenic steroids: entanglement for organ-specific toxicityAnkan Sinha, Vishal Kumar Deb, Abhijit Datta, et al.
Biofactors (Oxford, England)|February 4, 2025
Leveraging supramolecular systems in biomedical breakthroughsShreya Maity, Vishal Kumar Deb, Sayani Mondal, et al.
Frontiers in Bioengineering and Biotechnology|April 27, 2026
Advancements in nanomedicines for cancer therapy: targeting molecular signaling pathways, activating immune cells, and using photothermal immunomodulationVishal Kumar Deb, Abhishek Mukherjee, Surajit Pathak, et al.
Frontiers in Pharmacology|July 2, 2025
Pharmacological potential of natural chalcones: a recent studies and future perspectiveSuman Adhikari, Priyatosh Nath, Vishal Kumar Deb, et al.
Chempluschem|October 30, 2025
Metal Meets Nucleobase: A Cd(II)-Adenine Complex with Bridging Supramolecular Architectures and Antibacterial ActivitySourav Nath, Tanushree Sen, Vishal Kumar Deb, et al.
Pageof 2